Policy | October 26, 2021
NPPA fixes ceiling price for anti-diabetic generic medicines
A total of 12 generic medicines have been included in the list
A total of 12 generic medicines have been included in the list
As per the Department of Pharmaceuticals, the sector has expanded its reach across the country while strengthening domestic production capabilities and innovation
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
The surge has been driven largely by COCO stores, with 755 COCO and 165 FOFO outlets added this fiscal year
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
